We believe Mission and Margin is the business of healthcare.
Business of Healthcare (BOH) interviews feature innovations sustainably improving healthcare Mission & Margin. Each discussion includes a healthcare executive and innovator concentrating on the same problem. Think “Nightline” or “How I Built This” just for healthcare.
Recent guests have included Bernadette Spong, Chief Financial Officer, Orlando Health, Paul Kusserow, President & CEO, Amedisys, Blake Marggraff, Founder & Chief Executive Officer, Epharmix, and Charles Kolodkin, Chief Risk Officer, Cleveland Clinic.
The BOH audience of 19,000 senior executives from across healthcare . . . health system, payer, provider practice, government, pharma, device, health tech, and so on . . . access published interviews at www.BOHSeries.com.
Do PE-backed physician practices do a better job getting the right patients?
Gautam Shrikhande, MD, Chief Executive Officer of Pelvic Rehabilitation Medicine and Brian Rath, Partner, Lorient Capital join Business of Healthcare to explore the role of private equity in physician services.
Physicians want to serve patients with the highest value care at the best cost while being fairly compensated. Growth is a sign of a healthy, well-run practice. Ethical medical groups attract patients and increase revenue per patient by providing better outcomes, patient experience, and value as compared to local alternatives.
Some practices of these practices are choosing private equity to fund growth. As a source of capital, is private equity better at supporting growth? Does a practice taking PE investment run the risk of overly aggressive patient recruitment and billing? Do private equity partners help practices engage the right patients for growth?
We learn how one of these practices, PRM, partnered up with a PE firm to achieve velocity and growth. We look at the investment hypothesis, how they find the right patients for their services, how outcomes are measured and the role PE has with physician leaders.
McLeod Health's Catherine Lee, MBA, CPXP
You may think Patient Experience is a straightforward discipline. Cathy Lee, Corporate Vice President for Patient Experience, joins BOH host Matthew Hanis to explain the lenses of a modern patient experience program and her innovations in the space.
Arkansas Children's Jeff T. House & Feedback's Dean Browell, PhD
Digital ethnography observes healthcare decision making on community message boards. These insights bring a more distinct ‘voice of the customer’ to shape marketing and service delivery. Health system marketing leader Jeff T. House and digital ethnography Dean Browell, Ph.D. join BOH host Matthew Hanis to explain how digital ethnographic research is applied and some of the surprising insights which have emerged.
Atrium Health's Zeev Neuwirth, MD
Why are marketing tools, techniques and approaches so important to transforming healthcare? In his BOH interview, Zeev Neuwirth, MD says, “The field, in my estimation, that really understands what people want and need is the field of marketing.” Neuwirth describes the ‘marketing mindset’, stages systems go through embracing these techniques, the threat marketing experts Google, Amazon and CVS bring and the implications for payment reform, digital health and chronic disease management.
Banner Health’s Mark Jannone, MSME, CMBB
Can health systems engage consumers digitally to improve quality, cost and satisfaction? According to Mark Jannone, Senior Director, Banner Health’s Banner Innovation Group, the answer is a solid, “Yes.” He is helping to pilot digital ED triage and chatbot tools. Jannone reports the tools achieve a 35% reduction in inappropriate ED cases with 92% triage accuracy, decrease the time patients are in the ED by about 50% and increase net promoter scores by 40%.
Why the population health movement will save U.S. healthcare
“No outcome, no income,” says Dr. David Nash, Founding Dean Emeritus, Jefferson College of Population Health. JCPH is the nation’s first graduate school of population health. Nash describes the emergence of the population health movement, why fixing the US healthcare system is so important for our economy and our society, and concrete interventions such as going at risk with supply chain partners such as pharma.